Application | Comment | Organism |
---|---|---|
drug development | as an essential enzyme for the survival of GBS, GAPDH may be a potential target for developing antibacterial drugs | Streptococcus agalactiae |
Cloned (Comment) | Organism |
---|---|
recombinant expression of wild-type and mutant enzymes carrying a 20-residue N-terminal tag containing hexa-histidine and a thrombin cleavage sequence in Escherichia coli strain Rosetta (DE3) pLysS | Streptococcus agalactiae |
Crystallization (Comment) | Organism |
---|---|
purified wild-type enzyme in apo-form, in a mixed apo/holo-state (2 subunits with bound NAD and two without), and in a ternary complex, and purified mutant C152S enzyme in ternary complex, hanging drop vapor diffusion method, mixing of 15 mg/ml protein in 25 mM HEPES, pH 7.35, 00 mM NaCl, and 5 mM 2-mercaptoethanol with reservoir solution containing 20-28% PEG 4000, 0.1 M MES, pH 6.5, at 22°C, X-ray diffraction structure determination and analysis at 2.0 A resolution | Streptococcus agalactiae |
Protein Variants | Comment | Organism |
---|---|---|
C152S | site-directed mutagenesis, mutation of the catalytic residue inactivates the enzyme | Streptococcus agalactiae |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | the mammalian enzyme shows negative cooperativity | Streptococcus agalactiae |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
160000 | - |
recombinant tagged enzyme, gel filtration | Streptococcus agalactiae |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
D-glyceraldehyde 3-phosphate + phosphate + NAD+ | Streptococcus agalactiae | - |
3-phospho-D-glyceroyl phosphate + NADH + H+ | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Streptococcus agalactiae | Q9ALW2 | Group B Streptococcus | - |
Purification (Comment) | Organism |
---|---|
recombinant tagged wild-type and mutant enzymes from Escherichia coli strain Rosetta(DE3)pLysS by nickel affinity chromatography and gel filtration | Streptococcus agalactiae |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH + H+ | GAPDH-catalyzed phosphorylation of D-G3H takes place in two steps. In the first exergonic reaction the aldehyde group of D-glyceraldehyde 3-phosphate is converted into a carboxylic acid with concomitant reduction of NAD+ to NADH. The energy released by this reaction drives the endergonic second reaction in which a molecule of inorganic phosphate is transferred to the intermediate acid to form the product 3-phospho-D-glyceroyl phosphate. The reaction mechanism involves formation of a covalent bond between the thiol group of a conserved cysteine residue of GAPDH and the carbonyl C-atom of D-glyceraldehyde 3-phosphate resulting in the formation of the hemithioacetal intermediate. A hydride ion is transferred from D-glyceraldehyde 3-phosphate to the cofactor NAD+ to form NADH while oxidation of D-glyceraldehyde 3-phosphate by a water molecule generates a thioester intermediate. In the second step, the thioester is phosphorylated in a nucleophilic attack by an inorganic phosphate ion resulting in the formation of the product 3-phospho-D-glyceroyl phosphate and the release of the thiol-group of the active site cysteine | Streptococcus agalactiae |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
D-glyceraldehyde 3-phosphate + phosphate + NAD+ | - |
Streptococcus agalactiae | 3-phospho-D-glyceroyl phosphate + NADH + H+ | - |
r |
Subunits | Comment | Organism |
---|---|---|
homotetramer | a dimer of dimers, 4 * 44000, about, SDS-PAGE | Streptococcus agalactiae |
More | subunits of the dimers form the major interface P, overview. The second largest interface, the R interface, includes residues in the N-terminal domain that interact with NAD+ and loop residues 181-206 in the C-terminal domain of subunit pairs A, C and B, D. The smallest interface, the Q interface, shows limited interactions between residues in the ranges 43-53 and 274-291 of adjacent subunits A, D and B, C | Streptococcus agalactiae |
Synonyms | Comment | Organism |
---|---|---|
GAPDH | - |
Streptococcus agalactiae |
GBS GAPDH | - |
Streptococcus agalactiae |
glyceraldehyde-3-phosphate dehydrogenase | - |
Streptococcus agalactiae |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NAD+ | 1 NAD+ molecule per subunit, all four subunits have NAD+ bound in the active site, enzyme binding structure of wild-type and mutant C152S enzymes, overview | Streptococcus agalactiae | |
NADH | - |
Streptococcus agalactiae |
General Information | Comment | Organism |
---|---|---|
additional information | the phosphate group of the substrate is bound to the phosphate site in all four subunits, adenosyl binding pocket structure, comparison of group B Streptococcus ternary complex of enzyme with substrate and cofactor with human structure, comparative structure-function analysis of GBS GAPDH and hGAPDH, conformational changes upon ligand binding, overview. The active site residue Cys152 is positioned between the nicotinamide moiety of NAD+ and the side chain of active site residue His179 | Streptococcus agalactiae |
physiological function | enzyme GAPDH plays a key role in glycolysis and gluconeogenesis by catalyzing the reversible oxidative phosphorylation of D-glyceraldehyde 3-phosphate to the energy-rich intermediate glyceraldehyde 1,3-bisphosphate | Streptococcus agalactiae |